Yeah nothing has changed here.The share price went down after...

Yeah nothing has changed here.

The share price went down after the recent acquisition which has led to some weird sentiment that the direction of IHL has changed. It hasn't.

OSA results were excellent. Let's see how things look when final statement is put out around Phase 2 progress for OSA, and after our meeting with the FDA.

Market focus has moved away from the progress of our trials. That doesn't mean that IHL's focus has. Let's see how the market reacts when the next block of announcements come out